Sequent Scientific Share Price
Sequent Scientific Share Price Today
As of 5 Jul 2026, Sequent Scientific share price is ₹294.15. The stock opened at ₹293.95, compared to its previous close of ₹292.45. During today's trading session, Sequent Scientific share price moved in the range of ₹288.20 to ₹295.90, with an average price of ₹292.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹166.00 and a high of ₹297.00. On the performance front, Sequent Scientific share price has increased by 39.75% over the last six months and is up 58.24% on a year-on-year basis.
Sequent Scientific Returns Calculator
Sequent Scientific Shareholder Returns
Sequent Scientific Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Sequent Scientific Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,551.37 | ₹1,369.73 | ₹1,420.91 | ₹1,412.82 |
| Other Income | ₹14.69 | ₹10.96 | ₹6.39 | ₹10.85 |
| Total Revenue | ₹1,566.06 | ₹1,380.69 | ₹1,427.30 | ₹1,423.66 |
| Total Expenses | ₹1,516.77 | ₹1,417.94 | ₹1,500.16 | ₹1,370.73 |
| Profit Before Tax | ₹44.31 | -₹54.65 | -₹137.66 | ₹52.93 |
| Tax | ₹12.05 | -₹25.03 | -₹15.68 | ₹8.17 |
| Profit After Tax | ₹32.26 | -₹29.61 | -₹121.98 | ₹44.76 |
| EPS - Basic | ₹0.88 | -₹1.44 | -₹4.88 | ₹1.66 |
| EPS - Diluted | ₹0.85 | -₹1.44 | -₹4.88 | ₹1.63 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹44.31 | -₹54.65 | -₹137.66 | ₹52.93 |
| Income before WC changes | ₹199.35 | ₹90.32 | ₹83.06 | ₹146.66 |
| Change in Assets | -₹94.81 | -₹8.54 | -₹34.60 | -₹154.76 |
| Change in Liabilities | ₹6.43 | -₹37.14 | -₹17.01 | ₹65.47 |
| Change in WC | -₹88.38 | -₹45.67 | -₹51.61 | -₹89.30 |
| Cash flow from Operations | ₹83.36 | ₹30.60 | ₹16.81 | ₹30.60 |
| Cash flow from Investing | -₹24.78 | -₹5.92 | -₹64.96 | -₹95.57 |
| Cash flow from Financing | -₹60.73 | -₹1.44 | ₹32.23 | ₹67.26 |
| Total Cash Flow | -₹2.15 | ₹23.24 | -₹15.92 | ₹2.29 |
| Cash (Start of the year) | ₹64.81 | ₹41.57 | ₹57.50 | ₹53.74 |
| Cash (End of the year) | ₹62.66 | ₹64.81 | ₹41.57 | ₹57.50 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹729.02 | ₹729.45 | ₹749.33 | ₹667.79 |
| Current Assets | ₹872.92 | ₹810.94 | ₹779.79 | ₹783.18 |
| Total Assets | ₹1,601.95 | ₹1,540.38 | ₹1,529.12 | ₹1,450.97 |
| Current Liabilities | ₹505.00 | ₹626.99 | ₹558.76 | ₹512.12 |
| Net Current Asset | ₹367.92 | ₹183.95 | ₹221.04 | ₹271.06 |
| Non-Current Liabilities | ₹326.58 | ₹200.44 | ₹221.18 | ₹198.75 |
| Equity Capital | ₹770.36 | ₹712.96 | ₹749.19 | ₹740.10 |
| Total Equity & Liabilities | ₹1,601.95 | ₹1,540.38 | ₹1,529.12 | ₹1,450.97 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹178.26 | ₹168.52 | ₹222.69 | ₹219.63 |
| Other Income | ₹50.94 | ₹45.98 | ₹28.24 | ₹27.64 |
| Total Revenue | ₹229.19 | ₹214.50 | ₹250.93 | ₹247.27 |
| Total Expenses | ₹202.27 | ₹208.48 | ₹260.67 | ₹231.58 |
| Profit Before Tax | ₹22.05 | -₹0.24 | -₹9.75 | ₹15.69 |
| Tax | ₹6.25 | -₹0.86 | -₹3.67 | ₹0.89 |
| Profit After Tax | ₹15.79 | ₹0.62 | -₹6.08 | ₹14.80 |
| EPS - Basic | ₹0.63 | ₹0.03 | -₹0.24 | ₹0.60 |
| EPS - Diluted | ₹0.62 | ₹0.03 | -₹0.24 | ₹0.59 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹22.05 | -₹0.24 | -₹9.75 | ₹15.69 |
| Income before WC changes | ₹3.58 | -₹18.43 | -₹10.23 | ₹9.31 |
| Change in Assets | ₹1.49 | -₹11.45 | ₹71.40 | ₹0.85 |
| Change in Liabilities | -₹9.50 | ₹0.67 | -₹22.72 | ₹0.95 |
| Change in WC | -₹8.01 | -₹10.77 | ₹48.68 | ₹1.81 |
| Cash flow from Operations | -₹1.13 | -₹26.94 | ₹37.75 | ₹9.36 |
| Cash flow from Investing | -₹0.44 | ₹5.47 | -₹50.70 | -₹4.25 |
| Cash flow from Financing | ₹0.67 | ₹22.32 | ₹0.24 | ₹7.25 |
| Total Cash Flow | -₹0.90 | ₹0.84 | -₹12.71 | ₹12.36 |
| Cash (Start of the year) | ₹0.93 | ₹0.08 | ₹12.80 | ₹0.44 |
| Cash (End of the year) | ₹0.03 | ₹0.93 | ₹0.08 | ₹12.80 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,114.68 | ₹1,090.82 | ₹1,047.75 | ₹978.37 |
| Current Assets | ₹107.53 | ₹96.78 | ₹75.02 | ₹145.86 |
| Total Assets | ₹1,222.20 | ₹1,187.60 | ₹1,122.77 | ₹1,124.23 |
| Current Liabilities | ₹75.56 | ₹98.16 | ₹61.61 | ₹80.55 |
| Net Current Asset | ₹31.97 | -₹1.38 | ₹13.42 | ₹65.31 |
| Non-Current Liabilities | ₹3.99 | ₹2.21 | ₹2.80 | ₹2.59 |
| Equity Capital | ₹1,142.65 | ₹1,087.23 | ₹1,058.36 | ₹1,041.09 |
| Total Equity & Liabilities | ₹1,222.20 | ₹1,187.60 | ₹1,122.77 | ₹1,124.23 |
About Sequent Scientific
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Sequent Scientific Financial Highlights
- Revenue: Sequent Scientific reported revenue of ₹3,463.86 crore in FY26 vs ₹3,039.73 crore in FY25. It showed an increase of 13.95% on a yearly basis.
- Operating Profit: Sequent Scientific reported an operating profit of ₹349.02 crore in FY26 vs ₹13.18 crore in FY25. It showed an increase of 2,548.10% on a year-on-year basis.
- Net Profit: Sequent Scientific reported a net profit of ₹224.65 crore in FY26 vs ₹15.77 crore in FY25. It showed an increase of 1,324.54% on a yearly basis.
Sequent Scientific Quarterly Result Highlights
- Sequent Scientific reported revenue of ₹935.88 crore in Mar 2026, compared with ₹872.39 crore in Dec 2025, representing an increase of 7.28% on a quarter-on-quarter (QoQ) basis.
- Sequent Scientific reported an operating profit of ₹125.24 crore in Mar 2026, compared with ₹73.07 crore in Dec 2025, representing an increase of 71.40% on a quarter-on-quarter (QoQ) basis.
- Sequent Scientific reported a profit of ₹66.38 crore in Mar 2026, compared with ₹48.52 crore in Dec 2025, reflecting an increase of 36.81% on a QoQ basis.
- The earnings per share (EPS) of Sequent Scientific stood at ₹0.88 during Mar 2026.
Similar Stocks
FAQs on Sequent Scientific Share Price
What is Sequent Scientific share price today?
Sequent Scientific share price is ₹294.15 as on 03 Jul, 2026, 15:58 IST.
How has the Sequent Scientific share price performed in the past?
In the last 1 year, Sequent Scientific delivered a return of 58.24%. The Sequent Scientific share price hit a high of ₹297.00 and low of ₹166.00.
How much is the Mutual Fund shareholding in Sequent Scientific shares?
The Mutual Fund Shareholding in Sequent Scientific was 6.44% at the end of Mar 2026.
What is the the 52-week high and low of Sequent Scientific shares ?
The 52-week high and low of Sequent Scientific share is ₹297.00 and ₹166.00 as of 03 Jul, 2026.
What is the market cap of Sequent Scientific?
The market capitalisation of Sequent Scientific is ₹12,772.00 Crores as on 03 Jul, 2026.
What are the stock symbols of Sequent Scientific?
The stock symbol of Sequent Scientific is VIYASH on the NSE, 512529 on the BSE, and the ISIN is INE807F01027.
What was yesterday's closing price of Sequent Scientific shares ?
Sequent Scientific shares closed yesterday at ₹292.45 on NSE & ₹292.35 on BSE
How to buy Sequent Scientific shares?
To buy Sequent Scientific shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Sequent Scientific shares on Holidays?
No, shares of Sequent Scientific or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Sequent Scientific shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Sequent Scientific?
The PE and PB ratio of Sequent Scientific is 56.88 and 4.39 respectively, as on 03 Jul, 2026, 15:58 IST.